NanoenTek Incorporated operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares NanoenTek Incorporated with three other
companies in this sector in South Korea:
iNtRON Biotechnology Inc
sales of 20.58 billion Korean Won [US$17.43 million]
of which 55%
was Technology Export),
(24.08 billion Korean Won [US$20.39 million]
of which 100%
was Biotechnology business), and
Legochem Biosciences Inc
(25.24 billion Korean Won [US$21.38 million]
of which 90%
was Medical development).
During the year ended December of 2018, sales at
NanoenTek Incorporated were 25.80 billion Korean Won (US$21.85 million).
increase of 8.3%
versus 2017, when the company's sales were 23.81 billion Korean Won.
Sales of Diagnosis saw an increase
that was more than double the company's growth rate: sales were up
39.1% in 2018, from
9.93 billion Korean Won to 13.81 billion Korean Won.
Not all segments of NanoenTek Incorporated experienced an increase in sales in 2018:
sales of Biotechnology fell 13.7% to 11.99 billion Korean Won.